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Abstract
DNA sequence variants in genes involved in the innate immune response and secondary response to infection may confer
susceptibility to chronic otitis media with effusion and/or recurrent otitis media (COME/ROM). We evaluated single
nucleotide polymorphisms (SNPs) in 15 functional candidate genes. A total of 99 SNPs were successfully genotyped on the
Sequenom platform in 142 families (618 subjects) from the Minnesota COME/ROM Family Study. Data were analyzed for
association with COME/ROM using the Generalized Disequilibrium Test (GDT). Sex and age at exam were adjusted as
covariates, relatedness was accounted for, and genotype differences from all phenotypically discordant relative pairs were
utilized to measure the evidence of association between COME/ROM and each SNP. SNP rs2735733 in the region of the
mucin 5, subtypes A/C gene (MUC5AC) exhibited nominal evidence for association with COME/ROM (P = 0.002). Two
additional SNPs from this region had P values,0.05. Other variants exhibiting associations with COME/ROM at P,0.05
included the SCN1B SNP rs8100085 (P = 0.013), SFTPD SNP rs1051246 (P = 0.039) and TLR4 SNP rs2770146 (P = 0.038).
However, none of these associations replicated in an independent sample of COME/ROM families. The candidate gene
variants examined do not appear to make a major contribution to COME/ROM susceptibility, despite a priori evidence from
functional or animal model studies for a role in COME/ROM pathology.
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Introduction
Incidence and prevalence of otitis media (OM) has declined
since 2000 when infant immunization with pneumococcal
conjugate vaccine was adopted in the United States [1,2,3]. How-
ever, OM is still a very common childhood disease and remains a
major cause of morbidity and hearing loss in young children [4,5].
Children with an affected sibling are at higher risk, and OM
clusters in families across generations [6,7]. Twin studies in the
United States, Norway, England and Wales have reported a high
degree of heritability for recurrent and chronic OM [8,9,10],
defined as more than 3 episodes of acute OM in a year, or middle
ear fluid persisting for 3–4 months [11,12].
Our previous research on genetic contributions to chronic otitis
media with effusion and/or recurrent otitis media (COME/ROM)
include a complex segregation analysis of 173 families suggesting single
gene effects [13], a genome-wide linkage scan in 121 families providing
support for loci on chromosomes 10q and 19q [14], and an
investigation of the human ortholog (FBXO11) of the deaf mouse
mutant jeff gene, a single gene model of chronic/recurrent OM in our
family-based study [15].
We selected 15 candidate genes involved in the innate immune
response or the ability to clear infectious agents implicated in OM,
and evaluated common variation across the coding regions of
these genes for association with COME/ROM.
Methods
Ethics statement
This study was conducted under Institutional Review Board
approval at the University of Minnesota, Wake Forest University,
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and University of Pittsburgh, and adhered to the tenets of the
Declaration of Helsinki. Written consent was provided by all
participants or, in the case of children, by their parent or legal
guardian.
Subjects
Subjects who had tympanostomy tube surgery for COME/
ROM (probands) and their families were recruited for the study,
which has been described previously [14,15,16]. All probands
were treated with tympanostomy tubes. Participating first and
second degree relatives and parents of probands were classified as
affected or unaffected based on 1) treatment with tympanostormy
tubes, or 2) four data sources. Participants or parents completed a
history form documenting history and risk factors for COME/
ROM. The study otolaryngologist performed an ear examination
to determine presence of OM sequelae without knowledge of the
subject’s prior OM history, an audiologist conducted tympano-
metric testing at three frequencies (226, 630 or 710, and 1400) to
detect abnormal middle ear mechanics, and medical records were
abstracted to document tympanic membrane and middle ear
findings consistent with COME/ROM, and duration of OME.
Hearing was screened at 20 dB for speech frequencies. Phenotype
information comes from four sources: self or parent reported OM
history, ear examination, tympanometric findings, and medical
record abstract (see Material S1). Affected status of probands’
relatives was based on having positive findings from at least two of
these four sources (Table S1). A total of 142 families with at least
two individuals with the diagnosis of COME/ROM were used in
the candidate gene analyses.
We carried out a replication analysis in an independent study of
otitis media [17] that consisted of 1,583 genotyped individuals
from 441 Caucasian families. In order to assure a history of
significant ear disease, two or more full siblings who both or all
had undergone tympanostomy tube insertion were enrolled. The
need for tympanostomy tube insertion established that the subject’s
history of middle ear disease was truly significant, resulting in the
need for a surgical procedure. A subject was only considered
‘‘affected’’ if he/she had undergone tympanostomy tube insertion at
least once for recurrent/persistent OM, while a subject was
considered ‘‘unaffected’’ if he/she had never had tympanostomy
tubes and had no known history of recurrent/persistent OM. The
remaining subjects were considered as having ‘‘unknown’’ disease
status. Otoscopic examinations and tympanograms were conducted
at at entry if requested by the parent for patient information not
study data since the condition of the ears at entry did not determine
eligibility and the tubes may have been inserted many years prior to
study entry.
SNP selection and genotyping
DNA was isolated from blood using the Gentra PureGene
method (Qiagen, Valencia CA). Candidate genes were selected on
the basis of a role in innate host defense and acute inflammatory
response or chronic response and effusion, and prior evidence in
the literature for involvement in OM. We selected the largest
known isoform, added 5 kb upstream and downstream of the
coding region, and used HapMap CEU (Centre d’Etude
Polymorphisme Human) data (HapMap Data Rel#21/phaseII
Jul06, on NBCI B35 assembly, dbSNP b125) to identify SNPs with
minor allele frequency (MAF)$0.05. For mucin 5, subtypes A/C
(MUC5AC), we used the combined largest mRNA sequence
(AF015521; AJ298317; AF043909), which encompasses MUC5AC
NC_000011.8. We used the pairwise tagging option of Tagger
[18] (r2.0.8) to select the miminal tagSNP set for each gene.
Genotyping was conducted on the Sequenom platform using the
iPlex assay [19]. A total of 99 SNPs were successfully genotyped in
.95% of samples (see Table 1 for gene summary). Concordance
rates were calculated on the basis of 21 replicates included for
genotyping on the Sequenom platform at the same time that all
samples were assayed. Fifty-four SNPs were 100% concordant; 19
SNPs had one discordant call; 25 SNPs had two discordant calls;
and 1 SNP (rs778588 near CD14) had three discordant calls. The
concordance rates for nominally associated SNPs were 100%
(rs1051246, rs7396030, rs2075859, rs8100085) or 95% (rs2735733,
rs2770146; equivalent to one discordant call out of 21 or 20
replicate pairs respectively).
Candidate genes selected on the basis of their function in innate
host defense and acute inflammatory response included Toll-like
receptor 4 (TLR4) [20], Toll-like receptor 2 (TLR2) [21,22], Beta-
defensin 1 (DEFB1) [23], Surfactant protein A1 (SFTPA1)
[24,25,26], Surfactant protein D (SFTPD) [27,28], Interleukin-8
(IL8) [29,30,31], Interleukin-1 b (IL1B) [31], Interleukin 10 (IL10)
[20], and Lactotransferrin (LTF) [32]. Genes selected for their role
in chronic response and effusion were mucin 2 (MUC2) [33],
mucin 5, subtypes A/C (MUC5AC) [34], Mannose-binding lectin
precursor (MBL2) [35], CD14 antigen precursor (CD14) [36],
Sodium channel, voltage-gated, type I-b (SCN1B) [37], and
Ecotropic viral integration site 1 (EVI1) [38].
Statistical analyses
Deviations from Hardy Weinberg equilibrium (HWE) in
unaffected founder individuals were determined using the exact test
[39]. Four SNPs with small HWE P values were excluded from the
analysis and the remaining 99 SNPs have P.0.001. Data were
checked forMendelian errors using PedCheck [40] and pedstats [39]
and poorly performing SNPs or a minimal dataset required to
resolve errors were removed from analyses. Two monozygotic (MZ)
twin pairs were detected and incorporated in the association analysis.
Data were analyzed for association with COME/ROM using
the Generalized Disequilibrium Test (GDT) [41]. The GDT
utilizes the genotype differences of all phenotypically discordant
relative pairs in assessing association within families. This test has
been shown to be consistently more powerful than PDT [42],
FBAT [43] and several other family-based association tests for a
common disease [41]. It allows modeling of covariates and IBD
allele sharing, and information from extended pedigrees is
efficiently used without breaking extended pedigrees into multiple
nuclear families, as implemented in other methods. Compared to
other association tests that also examine between-family associa-
tion, the GDT method has the advantage of protecting from
population stratification between families, and being less affected
by genetic heterogeneity from multiple susceptibility genes. In
GDT analyses, we modeled sex and age at exam (considered a
proxy for generation/clinical practice) as covariates. Identity-by-
descent (IBD) statistics were estimated using the Merlin package
[44], and were incorporated in the GDT statistics.
Results
Population characteristics
The genotyped population included 618 individuals from 142
families (Table 2). One hundred thirty-two families were non-
Hispanic and of European ancestry. The 10 non-European
families consisted of seven families that described themselves as
non-Hispanic and of mixed race, one mixed race Hispanic family,
one Asian family, and one Native American family. As family-
based tests of association using the GDT are robust to population
stratification between families [41], all families were retained for
analyses.
COME/ROM Candidate Gene Analyses
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Associations with COME/ROM
A total of 99 SNPs encompassing 267 kb were successfully
genotyped in subjects from the Minnesota COME/ROM Family
Study. Age at exam was the factor most significantly associated
with COME/ROM. The odds ratio of association between one
year increment and COME/ROM was 0.94, with P= 1.2610216.
This strong association suggests the importance of adjusting for the
age effect in the candidate region association analysis. Although
the sex effect is not statistically significant after adjusting for age, it
was retained as a covariate in the candidate region association
analyses.
SNP rs2735733 in the MUC5AC gene region exhibited nominal
evidence (P= 0.002) for association with COME/ROM. At this
SNP, the T allele (minor allele frequency (MAF) 0.461) is more
frequent in unaffected individuals than in affected individuals, with
the allele frequency difference being 0.106. The odds ratio (OR) of
the minor allele was estimated to be 0.646, assuming a population
prevalence of 0.1. Although mucin 5B (MUC5B) was not initially
selected for study as an a priori candidate, the genomic region
genotyped, including the associated region of MUC5AC, overlaps
with MUC5B. In the region of chromosome 11 encompassing
MUC5AC (MUC5B) and MUC2, there were 21 SNPs in total
genotyped. Two other SNPs in this region had P values,0.05
(P= 0.049 at rs7396030 and P= 0.041 at rs2075859). The largest
effect of a single SNP is OR=1.57 at rs7396030. SNP rs7396030
is in weak LD with rs2075859 and rs2735733, with r2 0.036 and
0.013 respectively (D9 0.293 and 0.216 respectively); rs2075859
and rs2735733 are in LD, with r2 = 0.678 (and D9=0.987). Only
founders were used in the LD calculation, conducted using PLINK
[45]. Haplotype-based GDT analysis (as implemented in GDT
[41]) identified association (although not significant) between
haplotype CC at rs2075859 and rs2735733 and COME/ROM,
with P value 0.0097, which is consistent with the single SNP
association results. Further haplotype analysis based on three SNPs
does not produce any significant association (smallest P= 0.43).
We identified several other nominal SNP-COME/ROM associa-
tions, including the SCN1B rs8100085 (P=0.013), SFTPD rs1051246
(P=0.039), and TLR4 rs2770146 (P=0.038; Table 3).
Table 1. Selected candidate genes and number of SNPs genotyped.
Candidate gene
Gene
symbol
Chromo-
some
Gene size*
(kb)
Region
genotyped
(kb)
Total no.
SNPs in
region{
No. SNPs
successfully
genotyped
SNPs captured
at r2.0.8 Mean r2
N %
b-defensin 1 DEFB1 8 7.4 13.0 69 10 51 74% 0.982
CD14 antigen precursor CD14 5 1.9 9.8 9 4 9 100% 0.963
Ecotropic viral
integration site 1
EVI1 3 61.5 57.3 73 12 73 100% 0.978
Interleukin 1-b IL1B 2 7.0 9.1 10 3 8 80% 0.952
Interleukin 8 IL8 4 3.2 n/a 4 1 4 100% 0.983
Interleukin 10 IL10 1 4.9 7.8 21 5 9 43% 0.977
Lactotransferrin LTF 3 28.9 36.3 33 7 29 88% 0.966
Mannose-binding lectin
precursor
MBL2 10 6.3 13.5 46 10 46 100% 0.965
Mucin 2 MUC2 11 29.5 35.3 26 13 22 85% 0.990
Mucin 5, subtypes A/C MUC5AC 11 75.8 27.1 18 8 13 72% 0.968
Sodium channel,
voltage-gated, type I-b
SCN1B 19 9.8 n/a 1 1 1 100% 1.000
Surfactant Protein A1 SFTPA1 10 3.3 n/a 1 1 1 100% 1.000
Surfactant Protein D SFTPD 10 11.4 17.0 40 8 12 30% 1.000
Toll-like receptor 2 TLR2 4 21.8 23.1 12 8 10 83% 0.983
Toll-like receptor 4 TLR4 9 13.2 17.3 30 8 21 70% 0.951
Total 285.9 266.6 393 99 309 77% 0.916
*Largest isoform.
{CEU population, minor allele frequency (MAF).0.05, largest isoform of gene plus 5 kb upstream and downstream, based on HapMap data rel #24 phase II/Nov 08, on
NCBI B36 assembly, dbSNP B126.
doi:10.1371/journal.pone.0022297.t001
Table 2. Participant characteristics.
Trait Value (affected, unaffected)
Number of families 142
Number of subjects 618
Female 52.8%
Age, mean 6 SD 27.1616.6 (28.2616.5, 25.4616.5)
Affected with COME/ROM 61.5%
Caucasian 95.3%
Non-Hispanic 99.0%
Smokers in the home, mean 6 SD 0.7460.85
Attending day care centers 52.4% (50.8%, 55.0%)
Prior breastfeeding 57.7% (53.5%, 63.4%)
Allergies 30.7% (32.5%, 26.7%)
doi:10.1371/journal.pone.0022297.t002
COME/ROM Candidate Gene Analyses
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We also carried out association analysis in families consisting of
European American only (eight families were excluded) and
observed the same associations. All six associated SNPs listed in
Table 3 retain their significance with P values 0.027, 0.027, 0.045,
0.033, 0.002, and 0.022 respectively. An additional SNP (rs2672812)
in theMUC5A/MUC5B region also had a P value,0.05 (P=0.042).
We carried out a replication analysis of the six SNPs in Table 3
in an independent study [17]. The association results in the
replication study are shown in Table 4. The allele frequencies in
two studies are comparable. Only one SNP in the MUC2 region,
rs7396030, reached a P-value ,0.05 in the replication study
(unadjusted P= 0.0075; P = 0.022 after adjusting for sex). How-
ever, the risk allele in the replication study is the major allele,
opposite from our study. The allele flip could occur either by
chance (with a small probability of 0.025), or as a genuine allele
flip that is due to complex linkage disequilibrium with the causal
variant in the region (Clarke and Cardon, 2010). The most likely
explanation is that both results are false positives. In the replication
sample, the LD structure across the MUC5AC/MUC5B/MUC2
region was similar to that observed in the University of Minnesota
sample. LD between SNPs rs2075859 and rs2735733 was high
(r2 = 0.652, D9=0.988), but LD between these SNPs and MUC2
SNP rs7396030 was low (D9=0.022 and 0.034 respectively).
Discussion
We performed an evaluation of 15 functional candidate genes in a
well-characterized population of families from the Minnesota
COME/ROM Family Study. We utilized available HapMap data
and employed an LD-based tagging approach to survey common
variation in these genes. In some cases, few tagging SNPs were
available in the genic region at the time of SNP selection. The
strongest observed associations were with SNPs in the mucin 5
genomic region, encompassing both MUC2 andMUC5AC/MUC5B.
Middle ear inflammation stimulates the production and release
of inflammatory mediators, with subsequent upregulation of a
suite of mucin genes [46]. Mucins are a family of glycosylated
proteins that function as part of the mucociliary transport system
within the middle ear, binding pathogens and helping clear
cellular debris [46]. Muc5ac is upregulated in the OM rat model
[47], and is one of the genes expressed in mucoid effusion from
patients [48]. Similarly, muc5b is a major component of OME
effusions in a rabbit model of OME [49], and is present in middle
ear secretory cells of patients with COM [50]. Both MUC5AC and
MUC5B are located on chromosome 11, with overlapping coding
regions. One study found that a longer transcript of MUC5AC –
but not variants of MUC5B or MUC2 – was associated with OME
[51]. However, recent evidence showed MUC5B to be the
predominant mucin identified in middle ear effusions from
children with COME [52]. We plan to explore whether SNPs
associated with COME/ROM in the present study (or variants in
LD with them) influence isoform production or transcript stability.
Less robust associations were observed with SNPs in the SCN1B,
SFTPD and TLR4 genes. Interestingly, in rats whose ears were
inoculated with Streptococcus pneumoniae, one of the most common
pathogens in otitis media, scn1b, muc2 and muc5 were among the
genes upregulated [37], although polymorphisms of SCN1B do not
appear to have been investigated in COME/ROM previously.
Surfactant protein D (sftpd) knockout animals do not clear
influenza A viral infections [53]. SFTPD polymorphisms in
humans have been associated with surfactant protein D assembly,
function, and concentration [54], as well as severe respiratory
Table 3. GDT association results (P,0.05) for COME/ROM.
Chr SNP Position Allele Frequency P d OR Genes
9 rs2770146 117552892 G 0.307 0.038 20.062 0.736 TLR4
10 rs1051246 81687798 C 0.118 0.039 20.058 0.499 SFTPD*
11 rs7396030 1073364 T 0.196 0.049 0.078 1.565 MUC2
11 rs2075859 1207064 T 0.374 0.041 20.067 0.744 MUC5AC,MUC5B
11 rs2735733 1218216 T 0.461 0.002 20.106 0.646 MUC5AC,MUC5B
19 rs8100085 40214959 A 0.313 0.013 20.090 0.636 SCN1B
Note: Analyses are adjusted for sex and age at exam. d is the allele frequency difference between affected and unaffected individuals. The odds ratio (OR) of association
is converted from d and MAF, assuming a population prevalence of 0.1.
*This SNP was selected due to its proximity to COME/ROM candidate gene SFTPD, but is located within the mannose-binding protein-A pseudogene (MBL1P1) gene.
doi:10.1371/journal.pone.0022297.t003
Table 4. GDT association results for SNPs in Table 3 genotyped in the Caucasian subjects from the replication sample.
Chr SNP Position Allele Frequency P d OR Genes
9 rs2770146 117552892 G 0.324 0.84 0.006 20.200 TLR4
10 rs1051246 81687798 C 0.129 0.65 20.012 20.454 SFTPD
11 rs7396030 1073364 C* 0.802 0.022 0.057 2.295 MUC2
11 rs2075859 1207064 T 0.358 0.22 20.042 21.238 MUC5AC,MUC5B
11 rs2735733 1218216 T 0.447 0.11 20.052 21.617 MUC5AC,MUC5B
19 rs8100085 40214959 A 0.379 0.47 0.012 0.715 SCN1B
Note: Analyses are adjusted for sex.
*Opposite to allele reported in Table 3.
doi:10.1371/journal.pone.0022297.t004
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syncytial virus infections [27], a known precipitating factor for
OM [55]. In a mouse model of spontaneous OM, an exon 3
missense mutation in Tlr4 resulted in lipid A/lipopolysaccharide
(LPS) endotoxin insenstivity and an inability to clear Gram-
negative bacteria such as Haemophilus influenzae [56], a bacterium
frequent found in COME [57]. Similar defects in LPS response
due to TLR4 mutations have been shown to exist in humans [58].
This study has several strengths and limitations. The primary
strength is the family-based study design, permitting an analytical
approach robust to population stratification. Our newly developed
GDT approach also allowed us to take into account covariates age
and sex. The study included a small sample of non-European
families, consequently we are unable to draw any conclusions
about whether the observed associations are specific to European
American populations. Genotyping inaccuracy could potentially
have led to false negative results however, as noted in the Methods,
the concordance rates for the SNPs shown in Table 3 exceeded
95%. The candidate gene approach is necessarily limited by the
need for evidence of a role in OM pathology, thus we are
expanding our search for COME/ROM susceptibility alleles to a
genome-wide association study.
Epidemiological studies suggest that six episodes of AOM by
age six is not uncommon. From among individuals with medical
record abstracts (65% of participants), only 8 subjects (7 probands
and 1 sibling) had 6 episodes of OM by age 6, but did not have 3
episodes OM in any 12 month period. All 8 had tubes placement
surgery and were also positive for a history of COME/ROM by
either ear exam or tympanometry measures, so would have been
classified as affected even without meeting more stringent ROM
criteria. Although both studies used similar phenotype criteria to
determine affected status based on reported history of COME/
ROM, medical record review, ear examination and tympanograms,
for the primary study, the sibling of the proband did not need to
have undergone tympanostomy tube insertion. In contrast, in the
replication sample, both siblings were required to have tympanos-
tomy tube insertion. Failure to replicate nominal associations may
be a consequence of diagnostic differences between samples,
although it is probable that initial associations represent false
positive results. Although we cannot rule out the possibility of type 2
error due to lack of power in the initial sample, we can conclude that
there are no strong effects on COME/ROM risk by common
variants genotyped in these genes.
Since we define COME as middle ear fluid that lasts 3 or more
months, and ROM as 3 OM episodes in a year, or 6 episodes by
age 6, there is considerable overlap in our sample between COME
and ROM. It is not unreasonable to hypothesize that inadequate
production of mucins may predispose to ROM whereas excessive
production of mucins may predispose to COME, or that different
loci contribute to one or the other. Often patients with middle ear
fluid are prone to acute OM, so COME may predipose to ROM.
In the UMN sample there were 143 participants with a history of
both COME and ROM. Disentangling this relationship in future
analyses would require a larger sample.
Our results suggest that common variants in the selected
candidate genes do not appear to make a major contribution to
COME/ROM susceptibility, despite strong a priori hypotheses for
a role of these genes in disease pathology, suggesting agnostic
genome-wide analyses of COME/ROM populations may be a
more productive approach to identify susceptibility alleles.
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